Clinical Trials Directory

Trials / Completed

CompletedNCT03814031

Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function

Hepatic Vein Flow Assessment With Transesophageal Echocardiography for Postoperative Graft Function Prediction in Orthotopic Liver Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure HVF using TEE and assess the correlation with postoperative graft function indices such as early allograft dysfunction(EAD), prolonged INR, platelet, and total bilirubin.

Detailed description

During OLT, intraoperative TEE assessment of HVF (systolic and diastolic) were measured, and adjusted with donor graft weight. This index, HVF index, was assessed for correlation with EAD. HVF was calculated with hepatic vein area (cm2) x hepatic vein velocity (ml/s) in systole and diastole during the neohepatic phase. Investigators did ROC analysis to assess the predictive power for EAD, prolonged INR, platelet, and total bilirubin.

Conditions

Interventions

TypeNameDescription
OTHERNO internventionNO internvention

Timeline

Start date
2018-02-20
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2019-01-23
Last updated
2024-09-23
Results posted
2024-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03814031. Inclusion in this directory is not an endorsement.